LMSD: Lipid classification search results


LM_IDCommon NameSystematic NameSpecies ShorthandFormulaMass
LMPK13040001Hypericin (W)--C30H16O8504.0845
LMPK13040002Aloe-emodin (W)1,8-dihydroxy-3-(hydroxymethyl)-9,10-
anthracenedione
-C15H10O5270.0528
LMPK13040003Cascaroside A--C27H32O14580.1792
LMPK130400047-Chloroemodin--C15H9O5Cl304.0139
LMPK13040005Chrysophanic acid 9-anthrone--C15H12O3240.0786
LMPK13040006Chrysophanol--C15H10O4254.0579
LMPK13040007Chrysophanol 8-O-β-D-glucoside--C21H20O9416.1107
LMPK13040008Emodin (W)1,3,8-trihydroxy-6-methylanthracene-9,
10-dione
-C15H10O5270.0528
LMPK13040009Emodin 8-glucoside--C21H20O10432.1057
LMPK130400102-Isoprenylemodin--C20H18O5338.1154
LMPK130400112-Hydroxychrysophanol--C15H10O5270.0528
LMPK13040012Physcion 8-gentiobioside--C28H32O15608.1741
LMPK13040013Physcion 8-glucoside--C22H22O10446.1213
LMPK13040014Pseudohypericin--C30H16O9520.0794
LMPK13040015Cassic acid (W)4,5-dihydroxy-9,10-dioxoanthracene-2-
carboxylic acid
-C15H8O6284.0321
LMPK13040016Sennoside A--C42H38O20862.1957
LMPK13040017Sennoside B--C42H38O20862.1957
LMPK13040018Rubiadin1,3-dihydroxy-2-methyl-9,10-
anthracenedione
-C15H10O4254.0579
LMPK13040019Skyrin2,2',4,4',5,5'-hexahydroxy-7,7'-
dimethyl-[1S,1'-bianthracene]-9,9',10,
10'-tetrone
-C30H18O10538.0900
LMPK13040020Carviolin1,3-dihydroxy-6-(hydroxymethyl)-8-
methoxy-9,10-anthracenedione
-C16H12O6300.0634
LMPK13040021ωacetyl-Carviolin1,3-dihydroxy-6-(acetoxymethyl)-8-
methoxy-9,10-anthracenedione
-C18H14O7342.0740
LMPK130400221-O-Methylemodin1,3-Dihydroxy-8-methoxy-6-
methylanthracene-9,10-dione
-C16H12O5284.0685
LMPK13040023ω-Hydroxyemodin1,3,8-trihydroxy-6-(hydroxymethyl)-9,
10-anthracenedione
-C15H10O6286.0477
LMPK13040024Pachybasin1-hydroxy-3-methyl-9,10-anthracenedione-C15H10O3238.0630
LMPK13040025Penipurdin A1,6-dihydroxy-3-[(2S)-2-hydroxypropyl]-
8-methoxy-9,10-anthracenedione
-C18H16O6328.0947
LMPK13040026Penipurdin B1,8-dihydroxy-3-[(2S)-2-hydroxypropyl]-
9,10-anthracenedione
-C17H14O5298.0841
LMPK13040027Aurantio-obtusin1,3,7-trihydroxy-2,8-dimethoxy-6-
methyl-9,10-anthracenedione
-C17H14O7330.0740
LMPK13040028Physcion1,8-dihydroxy-3-methoxy-6-methyl-9,10-
anthracenedione
-C16H12O5284.0685
LMPK13040029Averantin1,3,6,8-tetrahydroxy-2-[(1S)-1-
hydroxyhexyl]-9,10-anthracenedione
-C20H20O7372.1209
LMPK130400308-O-methylchrysophanol1-Hydroxy-8-methoxy-3-methylanthracene-
9,10-dione
-C16H12O4268.0736
LMPK13040031ziganein-1-methyl ether5-Hydroxy-1-methoxy-3-methylanthracene-
9,10-dione
-C16H12O4268.0736
LMPK13040032Averythrin2-[(E)-hex-1-enyl]-1,3,6,8-
tetrahydroxyanthracene-9,10-dione
-C20H18O6354.1103
LMPK13040033Averufin2-Methyl-7,9,11-trihydroxy-3,4,5,6-
tetrahydro-2,6-epoxy-2H-anthra(2,3-b)
oxocin-8,13-dione
-C20H16O7368.0896
LMPK130400348-O-methyl averufin--C21H18O7382.1053
LMPK13040035Versicolorin B2,3,3a,12a-Tetrahydro-4,6,8-
trihydroxyanthra[2,3-b]furo[3,2-
d]furan-5,10-dione
-C18H12O7340.0583
LMPK13040036Methylaverantin1,3,6,8-tetrahydroxy-2-[(1S)-1-
methoxyhexyl]-9,10-anthracenedione
-C21H22O7386.1366